Dupuytren's contracture has a way of sneaking up on people. A small nodule in the palm, easy to ignore at first, gradually pulls one or more fingers into a bent position that resists straightening. Over time, that loss of extension affects handshakes, gloves, keyboards, steering wheels, and countless daily tasks that most people never think twice about. For patients who have reached the point where treatment is warranted, Xiaflex® offers a compelling non-surgical path that most people have never heard of.
What Causes Dupuytren's Contracture and Who Is at Risk?
Dupuytren's contracture is a progressive condition caused by thickening and scarring of the fascia beneath the skin of the palm. That thickened tissue forms cords that tighten over time, gradually pulling the fingers, most commonly the ring and small fingers, into flexion. The condition tends to run in families, is more common in men, and is associated with northern European ancestry, diabetes, and alcohol use, though it can occur without any of these risk factors.
The condition itself is not painful for most patients, but the functional limitation it creates is significant and worsens without treatment.
When Should You Seek Treatment for Finger Contracture?
Not every patient with Dupuytren's contracture needs immediate treatment. Small nodules without significant finger contracture can often be monitored over time. The threshold for intervention is generally when the contracture reaches approximately 30 degrees or more, or when the functional limitation begins to affect daily activities in a meaningful way.
A hand specialist can perform a tabletop test during evaluation: if the patient cannot lay their hand flat on a table, the contracture is typically significant enough to consider treatment.
How Xiaflex® Treats Dupuytren's Contracture Without Surgery
Xiaflex® (collagenase clostridium histolyticum) is an injectable enzyme that breaks down the collagen-rich cords causing the contracture. The treatment involves two office visits spaced approximately 48 hours apart. On the first visit, the enzyme is injected directly into the cord. On the second visit, the physician manipulates the finger to rupture the weakened cord and restore extension.
There is no incision, no general anesthesia, and no operating room. Recovery is measured in days to weeks rather than the months that surgical fasciectomy can require. Most patients return to light activity quickly and resume normal hand use within a few weeks of treatment.
For a hand surgeon who also performs wrist arthroscopy, complex fracture repair, carpal tunnel release, and compression neuropathy treatment, Xiaflex® fits naturally into a spectrum of care that includes both non-surgical and surgical options, chosen based on what is most appropriate for each individual patient.
What Are the Limitations of Xiaflex®?
Xiaflex® is not appropriate for every patient or every cord. Severe contractures, involvement of the thumb, or certain anatomical factors may make surgical fasciectomy a better option. Recurrence rates with Xiaflex® are real and comparable to those seen after surgery, though repeat injection is often possible when recurrence occurs. A thorough evaluation by a hand specialist is necessary to determine whether Xiaflex® or surgery is the more appropriate path.
Frequently Asked Questions About Xiaflex® for Dupuytren's Contracture
1. How effective is Xiaflex® for Dupuytren's contracture?
Clinical studies show that Xiaflex® significantly reduces contracture in most treated patients, with the greatest success in metacarpophalangeal joint contractures (where the finger meets the hand). Results in proximal interphalangeal joint contractures (the middle finger joint) are somewhat less predictable, which is worth discussing during consultation.
2. Is Xiaflex® covered by insurance?
Xiaflex® is FDA-approved for Dupuytren's contracture and is covered by most major insurance plans when medical necessity criteria are met. Coverage specifics vary by plan, and prior authorization is commonly required.
3. How long does recovery take after Xiaflex® treatment?
Most patients experience swelling, bruising, and soreness in the hand for one to two weeks following the manipulation visit. Return to light daily activity is typically possible within days, with full return to more demanding hand use within three to four weeks, depending on the extent of the contracture treated.
4. Can Dupuytren's contracture come back after Xiaflex®?
Yes. Recurrence is a known aspect of Dupuytren's disease regardless of treatment method, including surgery. If recurrence occurs after Xiaflex®, repeat injection is often an option, and the non-surgical nature of the treatment makes retreatment more straightforward than a repeat surgical procedure.
5. What is the difference between Xiaflex® and surgery for Dupuytren's contracture?
Surgical fasciectomy involves removing the diseased tissue through an incision in the palm, offering direct visualization and removal of the cords. Recovery typically takes several weeks to months. Xiaflex® dissolves the cord enzymatically through injection, requires no incision, and has a significantly shorter recovery timeline, though it may not be appropriate for every degree of contracture or every patient.
Hand conditions that are limiting what you can do with your own hands deserve more than a wait-and-see approach. Dr. Jason Shrouder-Henry sees patients at Illinois Bone & Joint Institute in Western Springs and Westmont, and evaluates Dupuytren's contracture patients individually to determine whether Xiaflex®, surgery, or continued monitoring is the most appropriate course of action.
Reference Links:
- Collagenase Treatment for Dupuytren Contracture of the Metacarpophalangeal Joint After Arthrodesis of the Proximal Interphalangeal Joint - PubMed Central
- Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol - PubMed Central
AUTHOR: Jason Shrouder-Henry, MD, MBA – Board-Certified Hand, Wrist, Elbow & Shoulder Surgeon
Jason Shrouder-Henry, MD, MBA is a board-certified, fellowship-trained orthopedic surgeon with additional subspecialty board certification in hand surgery. He treats conditions affecting the hand, wrist, elbow, and shoulder in both children and adults, with particular expertise in complex upper-extremity trauma and fracture care, degenerative and arthritic disorders, work- and sports-related injuries, and nerve and vascular conditions. Dr. Shrouder-Henry is committed to restoring patients to the highest possible level of function through thoughtful conservative care and, when appropriate, minimally invasive surgical techniques.
Credentials & Training
Dr. Shrouder-Henry earned his Medical Doctorate from Georgetown University School of Medicine and completed his Orthopaedic Surgery residency at the University of Toronto. He then pursued advanced fellowship training in Hand and Microvascular Surgery at the San Antonio Hand Center under the mentorship of David P. Green, MD, followed by a fellowship in Shoulder and Elbow Surgery at the University of Toronto.
He was awarded the Hirani Family Scholarship to attend the Northwestern Kellogg School of Management, where he obtained an MBA with a specialization in healthcare management and strategy.
Clinical Expertise & Research
In clinical practice, Dr. Shrouder-Henry focuses on comprehensive upper-extremity care, emphasizing individualized treatment plans that balance non-operative therapies with advanced surgical solutions when needed. His primary research interests center on the economic impact and healthcare utilization associated with fracture care across patients, private practices, and hospital systems, with the goal of improving value-based orthopedic care and patient outcomes.
He has served as a national panelist at major hand surgery conferences, including meetings of the American Society for Surgery of the Hand and the American Association for Hand Surgery, presenting on healthcare quality optimization, patient education, and practice management innovation. Dr. Shrouder-Henry is an active member of several professional organizations, including the American Academy of Orthopaedic Surgeons, the American Society for Surgery of the Hand, the American Association for Hand Surgery, and the Canadian Orthopaedic Association. Recognized for his clinical excellence and leadership in patient care, he has been honored as a Top Black Doctor and has been named a Top Doctor by Castle Connolly for several consecutive years.
Medical Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Shrouder-Henry.